SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
22-Mar-24 5:00 PM View: | Donoghoe Nicholas EVP, Chief Bus/Strat Officer | Abbvie Inc. (ABBV) | 20-Mar-24 | Private Sale | 21,082 | $176.30 | $3,716,760.00 | (27%) 76.98K to 55.9K | |
20-Mar-24 5:00 PM View: | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Abbvie Inc. (ABBV) | 18-Mar-24 | Sale | 32,839 | $178.79 | $5,871,290.00 | (35%) 95.12K to 62.28K | |
20-Mar-24 5:00 PM View: | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Abbvie Inc. (ABBV) | 18-Mar-24 | Option Exercise | 26,110 | $61.36 | $1,602,110.00 | 27% 95.12K to 121.23K | |
20-Mar-24 5:00 PM View: | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Abbvie Inc. (ABBV) | 18-Mar-24 | Option Sale | 26,110 | $178.79 | $4,668,210.00 | (22%) 121.23K to 95.12K | |
05-Mar-24 5:30 PM View: | Richmond Timothy J. EVP, Chief HR Officer | Abbvie Inc. (ABBV) | 01-Mar-24 | Option Exercise | 45,700 | $61.36 | $2,804,150.00 | 104% 43.82K to 89.52K | |
05-Mar-24 5:30 PM View: | Richmond Timothy J. EVP, Chief HR Officer | Abbvie Inc. (ABBV) | 01-Mar-24 | Planned Option Sale | 45,700 | $177.27 | $8,101,060.00 | (51%) 89.52K to 43.82K | |
05-Mar-24 5:30 PM View: | Richmond Timothy J. EVP, Chief HR Officer | Abbvie Inc. (ABBV) | 01-Mar-24 | Sale (Planned) | 29,980 | $177.27 | $5,314,440.00 | (68%) 43.82K to 13.84K | |
01-Mar-24 5:50 PM View: | Michael Robert A. PRES & CHIEF OPERATING OFFICER | Abbvie Inc. (ABBV) | 29-Feb-24 | Sale | 47,319 | $176.45 | $8,349,620.00 | (32%) 145.96K to 98.64K | |
01-Mar-24 5:50 PM View: | Siatis Perry C EVP, GC and Secretary | Abbvie Inc. (ABBV) | 29-Feb-24 | Sale | 9,891 | $177.39 | $1,754,550.00 | (49%) 20.29K to 10.4K | |
01-Mar-24 5:50 PM View: | Buckbee Kevin K SVP, Controller | Abbvie Inc. (ABBV) | 29-Feb-24 | Sale | 5,144 | $176.65 | $908,688.00 | (42%) 12.13K to 6.98K | |
01-Mar-24 5:50 PM View: | Michael Robert A. PRES & CHIEF OPERATING OFFICER | Abbvie Inc. (ABBV) | 29-Feb-24 | Option Exercise | 21,560 | $58.30 | $1,257,010.00 | 15% 145.96K to 167.52K | |
01-Mar-24 5:50 PM View: | Michael Robert A. PRES & CHIEF OPERATING OFFICER | Abbvie Inc. (ABBV) | 29-Feb-24 | Option Sale | 21,560 | $176.45 | $3,804,340.00 | (13%) 167.52K to 145.96K | |
01-Mar-24 5:50 PM View: | Gonzalez Richard A Chairman of the Board and CEO Director | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 110,249 | $178.99 | $19,733,500.00 | (14%) 767.96K to 657.72K | |
01-Mar-24 5:50 PM View: | Donoghoe Nicholas EVP, Chief Bus/Strat Officer | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 16,771 | $178.99 | $3,001,840.00 | (18%) 93.76K to 76.98K | |
01-Mar-24 5:50 PM View: | Michael Robert A. PRES & CHIEF OPERATING OFFICER | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 37,638 | $178.99 | $6,736,830.00 | (20%) 183.6K to 145.96K | |
01-Mar-24 5:50 PM View: | Siatis Perry C EVP, GC and Secretary | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 7,885 | $178.99 | $1,411,340.00 | (28%) 28.17K to 20.29K | |
01-Mar-24 5:50 PM View: | Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 23,966 | $178.99 | $4,289,670.00 | (10%) 250.14K to 226.17K | |
01-Mar-24 5:50 PM View: | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 4,914 | $178.99 | $879,557.00 | (17%) 28.17K to 23.26K | |
01-Mar-24 5:50 PM View: | Reents Scott T EVP, CHIEF FINANCIAL OFFICER | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 11,634 | $178.99 | $2,082,370.00 | (43%) 27.07K to 15.43K | |
01-Mar-24 5:50 PM View: | Gonzalez Richard A Chairman of the Board and CEO Director | Abbvie Inc. (ABBV) | 28-Feb-24 | Sale | 138,616 | $177.27 | $24,572,500.00 | (21%) 657.72K to 519.1K | |
01-Mar-24 5:50 PM View: | Hudson Thomas J SVP, CSO, GLOBAL RESEARCH | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 20,634 | $178.99 | $3,693,280.00 | (16%) 127.9K to 107.27K | |
01-Mar-24 5:50 PM View: | Richmond Timothy J. EVP, Chief HR Officer | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 23,847 | $178.99 | $4,268,370.00 | (35%) 67.66K to 43.82K | |
01-Mar-24 5:50 PM View: | Buckbee Kevin K SVP, Controller | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 5,339 | $178.99 | $955,628.00 | (28%) 19.21K to 13.87K | |
01-Mar-24 5:50 PM View: | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 26,121 | $178.99 | $4,675,400.00 | (22%) 121.24K to 95.12K | |
29-Feb-24 5:00 PM View: | Gonzalez Richard A Chairman of the Board and CEO Director | Abbvie Inc. (ABBV) | 27-Feb-24 | Gift | 4,195 | -- | -- | (< 1%) 772.16K to 767.96K | |
01-Mar-24 5:50 PM View: | Reents Scott T EVP, CHIEF FINANCIAL OFFICER | Abbvie Inc. (ABBV) | 23-Feb-24 | Option Sale | 14,140 | $177.44 | $2,509,000.00 | (34%) 41.2K to 27.07K | |
27-Feb-24 5:10 PM View: | Siatis Perry C EVP, GC and Secretary | Abbvie Inc. (ABBV) | 23-Feb-24 | Option Exercise | 13,753 | $137.36 | $1,889,120.00 | 49% 28.17K to 41.93K | (< 1%) |
27-Feb-24 5:10 PM View: | Siatis Perry C EVP, GC and Secretary | Abbvie Inc. (ABBV) | 23-Feb-24 | Planned Private Option Sale | 13,753 | $177.51 | $2,441,300.00 | (33%) 41.93K to 28.17K | |
01-Mar-24 5:50 PM View: | Reents Scott T EVP, CHIEF FINANCIAL OFFICER | Abbvie Inc. (ABBV) | 23-Feb-24 | Option Exercise | 14,140 | $61.36 | $867,630.00 | 52% 27.07K to 41.2K | |
23-Feb-24 5:00 PM View: | Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER | Abbvie Inc. (ABBV) | 21-Feb-24 | Option Exercise | 52,870 | $58.88 | $3,112,990.00 | 21% 250.14K to 303.01K | |
23-Feb-24 5:00 PM View: | Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER | Abbvie Inc. (ABBV) | 21-Feb-24 | Option Sale | 52,870 | $173.71 | $9,184,050.00 | (17%) 303.01K to 250.14K | |
20-Feb-24 5:15 PM View: | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 17,796 | -- | -- | 171% 10.38K to 28.17K | |
20-Feb-24 5:15 PM View: | Reents Scott T EVP, CHIEF FINANCIAL OFFICER | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 26,256 | -- | -- | 3245% 0.81K to 27.07K | |
20-Feb-24 5:15 PM View: | Siatis Perry C EVP, GC and Secretary | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 17,796 | -- | -- | 171% 10.38K to 28.17K | |
20-Feb-24 5:15 PM View: | Hudson Thomas J SVP, CSO, GLOBAL RESEARCH | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 46,572 | -- | -- | 57% 81.33K to 127.9K | |
20-Feb-24 5:20 PM View: | Richmond Timothy J. EVP, Chief HR Officer | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 53,827 | -- | -- | 389% 13.84K to 67.66K | |
20-Feb-24 5:15 PM View: | Buckbee Kevin K SVP, Controller | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 12,048 | -- | -- | 168% 7.16K to 19.21K | |
20-Feb-24 5:15 PM View: | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 58,960 | -- | -- | 95% 62.28K to 121.24K | |
20-Feb-24 5:15 PM View: | Gonzalez Richard A Chairman of the Board and CEO Director | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 248,865 | -- | -- | 48% 523.29K to 772.16K | |
20-Feb-24 5:17 PM View: | Donoghoe Nicholas EVP, Chief Bus/Strat Officer | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 37,853 | -- | -- | 68% 55.9K to 93.76K | |
20-Feb-24 5:15 PM View: | Michael Robert A. PRES & CHIEF OPERATING OFFICER | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 84,957 | -- | -- | 86% 98.64K to 183.6K | |
20-Feb-24 5:23 PM View: | Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 54,095 | -- | -- | 28% 196.04K to 250.14K | |
06-Feb-24 5:00 PM View: | Siatis Perry C EVP, GC and Secretary | Abbvie Inc. (ABBV) | 02-Feb-24 | Grant | 2,919 | $144.54 | $421,912.00 | 28% 10.38K to 13.3K | (6%) |
06-Feb-24 5:00 PM View: | Siatis Perry C EVP, GC and Secretary | Abbvie Inc. (ABBV) | 02-Feb-24 | Disposition | 2,919 | $170.00 | $496,230.00 | (22%) 13.3K to 10.38K | |
28-Dec-23 5:00 PM View: | Donoghoe Nicholas EVP, Chief Bus/Strat Officer | Abbvie Inc. (ABBV) | 26-Dec-23 | Private Sale | 2,912 | $154.72 | $450,545.00 | (5%) 58.81K to 55.9K | |
27-Sep-23 5:00 PM View: | Gonzalez Richard A Chairman of the Board and CEO Director | Abbvie Inc. (ABBV) | 25-Sep-23 | Gift | 42,000 | -- | -- | (7%) 594.71K to 552.71K | |
11-Sep-23 5:00 PM View: | Alpern Robert J Director | Abbvie Inc. (ABBV) | 07-Sep-23 | txn.W.title | 129 | -- | -- | < 1% 32.99K to 33.12K | |
02-Aug-23 5:07 PM View: | Gonzalez Richard A Chairman of the Board and CEO Director | Abbvie Inc. (ABBV) | 01-Aug-23 | Sale | 60,000 | $148.58 | $8,914,800.00 | (9%) 654.71K to 594.71K | |
02-Aug-23 5:07 PM View: | Gonzalez Richard A Chairman of the Board and CEO Director | Abbvie Inc. (ABBV) | 31-Jul-23 | Private Sale | 18,500 | $149.15 | $2,759,280.00 | (3%) 673.21K to 654.71K | |
12-May-23 5:00 PM View: | Strom Carrie C SVP & Pres Global Allerg Aesth | Abbvie Inc. (ABBV) | 11-May-23 | Payment of Exercise | 2,876 | $146.42 | $421,104.00 | (9%) 30.9K to 28.02K |